| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.300 | None | 1.000 | 4 | 0 | 2000 | 2014 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 2000 | 2000 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2000 | 2000 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 1991 | 2010 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 1992 | 2002 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 1998 | 2007 | ||||||||
|
cytochrome P450 family 2 subfamily E member 1 | 0.459 | 0.885 | 8.1E-09 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2002 | 2003 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 1998 | 2009 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2000 | 2000 | ||||||||
|
high mobility group box 1 | 0.368 | 0.923 | 0.82 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2009 | 2012 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2002 | 2006 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
retinol binding protein 4 | 0.493 | 0.808 | 0.52 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
prion protein | 0.445 | 0.923 | 6.3E-04 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
cell division cycle 42 | 0.458 | 0.846 | 0.79 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
SET nuclear proto-oncogene | 0.507 | 0.808 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
nuclear receptor subfamily 1 group H member 4 | 0.513 | 0.808 | 9.4E-04 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
CD40 ligand | 0.414 | 0.846 | 0.72 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
autophagy related 5 | 0.462 | 0.885 | 0.98 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
apoptosis inducing factor mitochondria associated 1 | 0.527 | 0.769 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
calpastatin | 0.541 | 0.846 | 4.1E-12 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 |